Skip to the page

Data / Form D filings / RxRevu, Inc.

RxRevu, Inc.: Form D filings

RxRevu, Inc., a health care company in Denver, CO, filed 6 Form D notices with the SEC between 2014 and 2023. The latest, on January 17, 2023, reports $6 million sold of a $10 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3001 Brighton Blvd., Suite 103, Denver, CO, 80216
Phone
(800) 360-4965
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1604586

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 17, 2023New notice$10,000,000$6,000,000$4,000,0001Dec 30, 2022sec.gov
Jul 8, 2021New notice$8,000,000$8,000,0001Jun 21, 2021sec.gov
Jan 6, 2017New notice$5,441,781$4,737,107$704,67444Dec 22, 2016sec.gov
Oct 28, 2016Amendment$4,500,000$3,815,000$685,00044Mar 14, 2014sec.gov
Oct 6, 2016Amendment$4,000,000$3,715,000$285,00044Mar 14, 2014sec.gov
Apr 9, 2014New notice$750,000$540,000$210,0007Mar 14, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen McHaleDirector
Kyle KiserExecutive Officer, Director
Andrew FirlikDirector
Steve LindsethExecutive Officer, Director
Christie CallahanExecutive Officer
Toby CosgroveDirector
Albert PrastDirector
Benton BarneyExecutive Officer
Richard ZaneDirector
Aaron CornellExecutive Officer
Daniel GallesDirector
Lew ParkerExecutive Officer

Other health care companies in Colorado that filed recently

Every Form D from the week of Jan 16, 2023 · All recent filings in Colorado · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what RxRevu, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.